Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Testicular germ cell tumors]

L M Dourthe1, M Ouachet, K Fizazi

  • 1Service de radiothérapie oncologie, Hôpital d'instruction des armées du Val-de-Grâce, Paris.

Bulletin Du Cancer
|November 17, 1998
PubMed
Summary

Testicular germ cell tumors are common in young men. Treatment varies by stage and type, including surgery, chemotherapy, and radiation, with ongoing research into new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple plan: chemotherapy-sparing approaches to early-stage and regional seminoma and nonseminoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis.

ESMO open·2025
Same author

Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Penile cancer: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024

Area of Science:

  • Oncology
  • Urology
  • Genetics

Context:

  • Testicular germ cell tumors (TGCTs) are the most frequent neoplasm in young men, with highest incidence in Scandinavian countries.
  • Cryptorchidism is a known predisposing factor for TGCT development.
  • Carcinoma in situ serves as the precursor to invasive germ cell tumors.

Purpose:

  • To outline the diagnosis, treatment strategies, and prognostic factors for testicular germ cell tumors.
  • To highlight the specific genetic markers, such as isochromosome of the short arm of chromosome 12, associated with germ cell tumors.
  • To discuss the risk stratification and management of different stages of seminoma and non-seminomatous germ cell tumors.

Summary:

  • Diagnosis involves clinical evaluation, tumor markers, and histology (seminoma or non-seminomatous).
  • Treatment protocols vary based on tumor stage and risk, including radical orchidectomy, chemotherapy (cisplatin-based regimens like BEP), radiation, and surgery for residual masses.
  • Relapsed cases are treated with salvage chemotherapy, and novel agents like paclitaxel are under investigation.

Impact:

  • Establishes current standards of care for testicular germ cell tumors, aiding clinicians in treatment decisions.
  • Provides insights into the genetic underpinnings of TGCTs, potentially guiding future research.
  • Informs patient prognosis and management strategies based on risk stratification, aiming to improve outcomes.

Related Experiment Videos